相似文献/References:
[1]胡玲,胡健蓉,徐凤仪,等.血管内皮生长因子在子宫内膜癌中的表达及其意义[J].中国计划生育和妇产科,2011,(01):0.
HU Ling,HU Jian-rong,XU Feng-yi,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(01):0.
[2]梁寿珺,范余娟,黄尹,等.血管内皮生长因子+936TC基因多态性同子宫内膜异位症遗传易感性的Meta分析[J].中国计划生育和妇产科,2012,(04):0.
LIANG Shou-jun,FAN Yu-juan*,HUANG Yin,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(01):0.
[3]冯永冬,黎克全.凝血功能及血管内皮生长因子与子宫肌瘤引起月经过多的相关性研究[J].中国计划生育和妇产科,2014,(03):0.
[4]王本昀,刘洁.血管内皮生长因子、妊娠相关蛋白A联合检测在鉴别诊断先兆流产及异位妊娠中的价值[J].中国计划生育和妇产科,2015,(10):0.
WANG Ben-yun,LIU Jie,[J].Chinese Journal of Family Planning & Gynecotokology,2015,(01):0.
[5]王军玲,罗淑红.血管内皮生长因子及其可溶性受体在子宫内膜异位症患者血清、腹腔液中的表达及意义[J].中国计划生育和妇产科,2016,(04):0.
WANG Jun-ling,LUO Shu-hong,[J].Chinese Journal of Family Planning & Gynecotokology,2016,(01):0.
[6]陈薇,陆月梅*,王琛琛,等.血管内皮生长因子、血管生成素- 2及巨噬细胞移动抑制因子在子宫内膜异位症患者血清中的表达水平及在疾病发生发展中的意义[J].中国计划生育和妇产科,2018,(10):47.
CHEN Wei,LU Yue-mei*,WANG Chen-chen,et al.Expression of MMIF, Ang-2 and VEGF in serum of patients with endometriosis and its significance in the development of disease[J].Chinese Journal of Family Planning & Gynecotokology,2018,(01):47.
[7]王丹,胡萍,陈小燕,等.子宫内膜癌中胎盘特异性蛋白和胎盘生长因子的表达及其临床意义[J].中国计划生育和妇产科,2019,(5):74.
WANG Dan,HU Ping,CHEN Xiao-yan,et al.Expression and clinical significance of PLAC1 and PLGF
in endometrial carcinoma[J].Chinese Journal of Family Planning & Gynecotokology,2019,(01):74.
[8]于婉莹,曾彬,郭婉茹,等.培养液生长因子评估与胚胎质量及发育潜能的
关系研究[J].中国计划生育和妇产科,2019,(7):37.
YU Wan-ying,ZENG bin,Guo Wan-ru,et al.Evaluation of embryo quality and potential development by culture medium growth factors[J].Chinese Journal of Family Planning & Gynecotokology,2019,(01):37.